Clinical Laboratory Standards Institute (CLSI) Guidelines for Severe Combined Immunodeficiency (SCID)

Date: September 20, 2017

Clinical Laboratory Standards Institute (CLSI) has developed guidelines for Severe Combined Immunodeficiency (SCID): Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles; Approved Guideline. This document addresses laboratory issues as well as short-term follow-up for SCID.

Additional resources from CLSI can be found here